Irisbond Crowdbonding, S.L.

Irisbond Crowdbonding, S. L. is a Spain-based company specializing in innovative eye-tracking technology that facilitates communication for individuals with speech difficulties and limited mobility through its dynamic communicators. Founded in 2013 and headquartered in Donostia, Spain, Irisbond Crowdbonding, S.

L. develops eye-tracking solutions designed to assist individuals with communication challenges. The firm has successfully completed a total of 3 funding deals, with the latest round in October 2023 raising EUR 2 million from Spri and other investors, bringing the total amount raised to EUR 2 million. The company is led by Founder and CEO Eduardo Torrecilla.

IRISBOND specializes in eye-tracking technology aimed at enhancing communication and interaction for individuals with speech difficulties and limited mobility. Its core product offerings include dynamic communicators that utilize eye-tracking to enable users to engage with devices and communicate effectively. This technology is particularly beneficial for those requiring Augmentative and Alternative Communication (AAC) solutions, facilitating independence and interaction in various contexts. The company's products have significant applications in health sectors, aiding in disease prevention and diagnosis by minimizing physical contact and assisting in the evaluation of cognitive disorders.

IRISBOND primarily serves clients in the healthcare industry, educational institutions, and individuals with disabilities, with its solutions available across European and North American markets. IRISBOND operates on a business model that encompasses direct-to-consumer sales as well as partnerships with healthcare providers and educational institutions. Revenue is generated through the sale of its eye-tracking systems and dynamic communicators, which are marketed as essential tools for individuals who require alternative forms of communication. For the year 2022, the firm reported revenue of EUR 2,430,974.

40 and an EBITDA of EUR 349,517. 70. In October 2023, Irisbond Crowdbonding, S. L.

raised EUR 2 million in venture funding to support its expansion efforts in the United States and enhance its competitiveness in augmentative and alternative communication technologies. The company plans to focus on improving its testing and certification processes in clinical and hospital settings as it targets new markets for its innovative products.